Status:

COMPLETED

Maximal Exercise Capacity, Physical Activity and Respiratory Muscle Strength in Peripheral Artery Disease

Lead Sponsor:

Gazi University

Conditions:

Peripheral Arterial Disease

Eligibility:

All Genders

18-80 years

Brief Summary

The primary aim of the study is to evaluate the maximal and submaximal exercise capacity in patients with peripheral artery disease (PAD). The secondary aim of the study is assessment of physical acti...

Detailed Description

Peripheral artery disease is characterized by reduced exercise capacity, physical activity level and intermittent claudication. The number of studies investigating maximal and submaximal exercise capa...

Eligibility Criteria

Inclusion

  • Patients;
  • Diagnosed with peripheral artery disease
  • Ankle brachial index (ABI)≤ 1,5 or calcified vessel response
  • Clinically stable and under standard medication patients will be included

Exclusion

  • Patients with;
  • Ischemic amputation
  • Any pulmonary disease
  • Unstable coronary artery disease
  • Orthopedic and neurological problems
  • Acute infection
  • Myocardial infarction or major surgery in the last 3 months will be excluded
  • Healthy controls: Ages 18-80 years will be included
  • With any diagnosed disease and smoking more than 10 packsyears will be excluded

Key Trial Info

Start Date :

January 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 31 2019

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT03458754

Start Date

January 1 2018

End Date

March 31 2019

Last Update

November 24 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Gazi University

Ankara, Turkey (Türkiye), 06500

2

Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation

Yenimahalle, Turkey (Türkiye)